X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.expresspharma.in/granules-indias-vizag-facility-completes-us-fda-inspection-with-zero-483-observations/
https://www.cnbctv18.com/business/companies/stocks-in-news-graunles-india-share-price-performance-usfda-inspection-andhra-facility-form-483-19396180.htm
https://www.reuters.com/business/healthcare-pharmaceuticals/paracetamol-maker-granules-india-posts-marginal-rise-q3-profit-2024-01-23/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214556
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-india-gets-usfda-nod-for-generic-drug-used-for-short-term-treatment-of-heartburn/articleshow/104550296.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.reuters.com/business/healthcare-pharmaceuticals/paracetamol-maker-granules-india-q1-profit-hurt-by-cyber-attack-disruptions-2023-08-09/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216509
https://www.indianpharmapost.com/news/granules-india-and-central-bureau-of-narcotics-unite-to-tackle-drug-abuse-14335
https://www.reuters.com/business/aerospace-defense/paracetamol-maker-granules-india-flags-significant-operations-hit-cyber-attack-2023-06-29/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217878
Market Place
Share 
